Insider Transactions in Q2 2022 at Enzo Biochem Inc (ENZ)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
75,000
+1.81%
|
$150,000
$2.2 P/Share
|
|
Jun 15
2022
|
Hamid Erfanian Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,600
+1.65%
|
$9,200
$2.19 P/Share
|
|
Jun 15
2022
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
50,000
+1.24%
|
$100,000
$2.21 P/Share
|
|
Jun 14
2022
|
David Bench Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
3,500
+36.84%
|
$7,000
$2.15 P/Share
|
|
Apr 27
2022
|
Ian B. Walters Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,063
+50.0%
|
-
|
|
Apr 27
2022
|
Bradley Louis Radoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,063
+0.98%
|
-
|
|
Apr 27
2022
|
Mary Tagliaferri Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,063
+50.0%
|
-
|
|
Apr 14
2022
|
Bradley Louis Radoff Director |
BUY
Grant, award, or other acquisition
|
Indirect |
30,000
+6.52%
|
$60,000
$2.91 P/Share
|
|
Apr 14
2022
|
David Bench Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
1,620
+39.32%
|
$3,240
$2.9 P/Share
|
|
Apr 13
2022
|
Hamid Erfanian Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+3.57%
|
$20,000
$2.9 P/Share
|
|
Apr 13
2022
|
David Bench Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
880
+50.0%
|
$1,760
$2.9 P/Share
|